The Anti-Mesothelin Monoclonal Antibody Amatuximab Enhances the Anti-Tumor Effect of Gemcitabine Against Mesothelin-High Expressing Pancreatic Cancer Cells in a Peritoneal Metastasis Mouse Model
Oncotarget - United States
doi 10.18632/oncotarget.26117
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 8, 2018
Authors
Publisher
Impact Journals, LLC